Pre-Exposure Prophylaxis study (treated before exposed to the virus)
et al., Annals of the Rheumatic Diseases, 79:7, 859-866, doi:10.1136/annrheumdis-2020-217871 (Peer Reviewed)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Analysis of rheumatic disease patients showing no significant association between antimalarial therapy and hospitalisation, OR=0.94 [0.57-1.57], p
=0.82 after adjustments.
hospitalization, ↓3.3%, p=0.82
(odds ratio converted to relative risk)
Please send us corrections, updates, or comments.